GC
APYX icon

Globeflex Capital’s Apyx Medical APYX Stock Holding History

Globeflex Capital’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-200
Closed -$1K – 464
2016
Q4 		$1K Hold
200
– – ﹤0.01% 396
2016
Q3 		$1K Buy
+200
New +$649 ﹤0.01% 387
2015
Q1 		– Sell
-262
Closed -$1K – 535
2014
Q4 		$1K Sell
262
-23
-8% -$89 ﹤0.01% 420
2014
Q3 		$1K Sell
285
-80
-22% -$325 ﹤0.01% 438
2014
Q2 		$1K Sell
365
-72
-16% -$291 ﹤0.01% 485
2014
Q1 		$1K Hold
437
– – ﹤0.01% 493
2013
Q4 		$0 Hold
437
– – ﹤0.01% 615
2013
Q3 		$1K Hold
437
– – ﹤0.01% 473
2013
Q2 		$1K Buy
+437
New +$1.47K ﹤0.01% 477

Other funds holding APYX

GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CPA
Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return

Globeflex Capital's APYX Position: Q1 2017 in Review

Globeflex Capital sold out of Apyx Medical (APYX) in Q1 2017, closing a stake of 200 shares — an estimated $1K sold.

Globeflex Capital first reported a position in APYX in Q2 2013 and held it in 9 quarters. The position peaked at $1K in Q4 2016. 37 funds tracked by Wall St. Rank hold APYX as of Q1 2017.

  • Globeflex Capital reported no remaining Apyx Medical position as of Q1 2017 after selling out during the quarter.
  • Globeflex Capital sold 200 Apyx Medical shares in Q1 2017, an estimated $1K.
  • Globeflex Capital first reported a position in Apyx Medical in Q2 2013 and held it in 9 quarters.
  • Globeflex Capital's Apyx Medical position peaked at $1K in Q4 2016.
  • 37 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2017.

Based on Globeflex Capital's 13F filing for Q1 2017, filed 12 May 2017.